194 related articles for article (PubMed ID: 30411544)
1. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.
Nakagawa N; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Cancer Med; 2018 Dec; 7(12):6020-6029. PubMed ID: 30411544
[TBL] [Abstract][Full Text] [Related]
2. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
[TBL] [Abstract][Full Text] [Related]
3. Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset.
Ito Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Ann Surg Oncol; 2020 Jan; 27(1):268-275. PubMed ID: 31493125
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
5. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.
Hayashi S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Gastric Cancer; 2019 Jul; 22(4):853-863. PubMed ID: 30483985
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.
Ikoma N; Chen HC; Wang X; Blum M; Estrella JS; Fournier K; Mansfield P; Ajani J; Badgwell BD
Ann Surg Oncol; 2017 Sep; 24(9):2679-2687. PubMed ID: 28332034
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy.
Lee JH; Son SY; Lee CM; Ahn SH; Park DJ; Kim HH
Gastric Cancer; 2014; 17(3):529-36. PubMed ID: 24101155
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.
Huang B; Sun Z; Wang Z; Lu C; Xing C; Zhao B; Xu H
BMC Cancer; 2013 Feb; 13():57. PubMed ID: 23379700
[TBL] [Abstract][Full Text] [Related]
11. Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Takahashi R; Ohashi M; Kano Y; Ida S; Kumagai K; Nunobe S; Chin K; Yamaguchi K; Nagino M; Sano T; Hiki N
Gastric Cancer; 2019 Nov; 22(6):1256-1262. PubMed ID: 30877407
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
Cao L; Selby LV; Hu X; Zhang Y; Janjigian YY; Tang L; Coit DG; Brennan MF; Strong VE
J Surg Oncol; 2016 Jun; 113(7):745-9. PubMed ID: 27040753
[TBL] [Abstract][Full Text] [Related]
13. Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
Kano Y; Ohashi M; Muneoka Y; Takahari D; Chin K; Yamaguchi K; Ida S; Kumagai K; Makuuchi R; Sano T; Nunobe S
Eur J Surg Oncol; 2021 Dec; 47(12):3097-3104. PubMed ID: 33931261
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer.
Kamei T; Kitayama J; Yamashita H; Nagawa H
World J Surg; 2009 Jun; 33(6):1240-6. PubMed ID: 19308640
[TBL] [Abstract][Full Text] [Related]
15. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
Li F; Zhang R; Liang H; Liu H; Quan J
J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
[TBL] [Abstract][Full Text] [Related]
16. Tumor size ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset.
Tsutsuyama M; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
World J Surg; 2020 Jan; 44(1):194-201. PubMed ID: 31552460
[TBL] [Abstract][Full Text] [Related]
17. Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis.
Matsunaga T; Ishiguro R; Miyauchi W; Shishido Y; Miyatani K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Saito H; Fujiwara Y
BMC Surg; 2021 Jan; 21(1):33. PubMed ID: 33422067
[TBL] [Abstract][Full Text] [Related]
18. Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.
Ichikura T; Fujino K; Ikawa H; Tomimatsu S; Uefuji K; Tamakuma S
Surg Today; 1993; 23(9):759-64. PubMed ID: 8219607
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study.
Kus T; Kose F; Aktas G; Arslan UY; Sedef AM; Cinkir HY; Dirikoc M; Akkus G; Ozdemir NY
J Gastrointest Cancer; 2021 Jun; 52(2):634-642. PubMed ID: 32578034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
